Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02819765 · ClinicalTrials.gov registry record

Deep Phenotyping in Patients With ALS

A clinical trial of ALS and Motor Neuron Disease, sponsored by Barrow Neurological Institute.

Completed
Registry status
32
Enrollment target
7
Study locations

NCT02819765 is a study of ALS and Motor Neuron Disease that has completed, run by Barrow Neurological Institute. The registered enrollment target is 32 participants, below the 1,035-participant average among 19 other ALS trials with a reported enrollment target (97% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02819765, a study of ALS and Motor Neuron Disease, has completed, sponsored by Barrow Neurological Institute.

COMPLETED
Registry status
32 participants
Enrollment target
7
Study locations

Study Summary

This study aims to establish a biorepository and phenotyping database to investigate longitudinal changes in ALS subjects. Blood, including DNA and RNA, cerebrospinal fluid (CSF) and electrophysiologic measures will be collected every 6 months over 1 and a half years. The database and specimen repository will be made available to ALS researchers on a merit basis.

Conditions Studied

ALS Motor Neuron Disease

Study Locations (7)

Pennsylvania

  • Temple University - Philadelphia
  • University of Pittsburgh Medical Center - Pittsburgh

Arizona

  • Barrow Neurological Institute - Phoenix

Michigan

  • Spectrum Health - Grand Rapids

New York

  • Hospital for Special Surgery (HSS) - New York

Oregon

  • Oregon Health & Science University - Portland

South Carolina

  • Department of Neurosurgery & Neurology | Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2017-02-07
Est. Completion 2021-11-09

Sponsor

Barrow Neurological Institute

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02819765

The ClinicalTrials.gov registry entry for NCT02819765 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,035-participant average among 19 other ALS trials with a reported enrollment target (97% lower). The listed sponsor is Barrow Neurological Institute, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with ALS appearing as the primary indexed condition, and to 0 interventions.

NCT02819765 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Pennsylvania, Arizona, Michigan.

Frequently Asked Questions

What is clinical trial NCT02819765 about?

NCT02819765 is a clinical study titled "Deep Phenotyping in Patients With ALS". This study aims to establish a biorepository and phenotyping database to investigate longitudinal changes in ALS subjects. Blood, including DNA and RNA, cerebrospinal fluid (CSF) and electrophysiologic measures will be collected every 6 months over 1 and a half years. The database and specimen repos...

What is the current status of trial NCT02819765?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2017-02-07. Estimated completion is 2021-11-09.

What conditions does trial NCT02819765 study?

This clinical trial studies the following conditions: ALS, Motor Neuron Disease.

Who is sponsoring clinical trial NCT02819765?

This trial is sponsored by Barrow Neurological Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02819765 being conducted?

This trial has 7 study locations across Arizona, Michigan, New York, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for ALS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

ALS

All registered trials for this condition

Motor Neuron Disease

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.